{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T21:27:35Z","timestamp":1789939655523,"version":"4.0.1"},"reference-count":64,"publisher":"Elsevier BV","issue":"31","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.vaccine.2009.04.036","type":"journal-article","created":{"date-parts":[[2009,5,4]],"date-time":"2009-05-04T08:45:36Z","timestamp":1241426736000},"page":"4209-4218","source":"Crossref","is-referenced-by-count":34,"title":["A live guinea pig cytomegalovirus vaccine deleted of three putative immune evasion genes is highly attenuated but remains immunogenic in a vaccine\/challenge model of congenital cytomegalovirus infection"],"prefix":"10.1016","volume":"27","author":[{"given":"Megan M.","family":"Crumpler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Yeon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"McVoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R.","family":"Schleiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.vaccine.2009.04.036_bib1","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1001\/jama.1986.03380140074025","article-title":"Primary cytomegalovirus infection in pregnancy. Incidence, transmission to fetus, and clinical outcome","volume":"256","author":"Stagno","year":"1986","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.vaccine.2009.04.036_bib2","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1086\/426456","article-title":"Detection of cytomegalovirus (CMV) DNA by polymerase chain reaction is associated with hearing loss in newborns with symptomatic congenital CMV infection involving the central nervous system","volume":"191","author":"Bradford","year":"2005","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2009.04.036_bib3","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1552-6909.2002.tb00026.x","article-title":"Cytomegalovirus infection: perinatal implications","volume":"31","author":"Damato","year":"2002","journal-title":"J Obstet Gynecol Neonat Nurs"},{"issue":"1","key":"10.1016\/j.vaccine.2009.04.036_bib4","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0095-5108(18)30189-1","article-title":"Cytomegalovirus infection in the pregnant mother, fetus, and newborn infant","volume":"24","author":"Nelson","year":"1997","journal-title":"Clin Perinatol"},{"issue":"4","key":"10.1016\/j.vaccine.2009.04.036_bib5","first-page":"151","article-title":"Seroprevalence of cytomegalovirus, toxoplasma and parvovirus in pregnancy","volume":"41","author":"Wong","year":"2000","journal-title":"Singapore Med J"},{"issue":"22","key":"10.1016\/j.vaccine.2009.04.036_bib6","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1056\/NEJM197706022962203","article-title":"Congenital cytomegalovirus infection","volume":"296","author":"Stagno","year":"1977","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.vaccine.2009.04.036_bib7","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1136\/adc.53.7.536","article-title":"Congenital cytomegalovirus infection in newborn infants of mothers infected before pregnancy","volume":"53","author":"Schopfer","year":"1978","journal-title":"Arch Dis Child"},{"issue":"10","key":"10.1016\/j.vaccine.2009.04.036_bib8","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1056\/NEJM199203053261003","article-title":"The outcome of congenital cytomegalovirus infection in relation to maternal antibody status","volume":"326","author":"Fowler","year":"1992","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.vaccine.2009.04.036_bib9","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1084\/jem.20050882","article-title":"Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects","volume":"202","author":"Sylwester","year":"2005","journal-title":"J Exp Med"},{"issue":"9","key":"10.1016\/j.vaccine.2009.04.036_bib10","doi-asserted-by":"crossref","first-page":"5226","DOI":"10.1128\/JVI.77.9.5226-5240.2003","article-title":"Ex vivo profiling of CD8+-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers","volume":"77","author":"Elkington","year":"2003","journal-title":"J Virol"},{"issue":"11","key":"10.1016\/j.vaccine.2009.04.036_bib11","doi-asserted-by":"crossref","first-page":"7767","DOI":"10.4049\/jimmunol.179.11.7767","article-title":"Human cytomegalovirus differentially controls B cell and T cell responses through effects on plasmacytoid dendritic cells","volume":"179","author":"Varani","year":"2007","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2009.04.036_bib12","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.immuni.2008.07.017","article-title":"Memory inflation during chronic viral infection is maintained by continuous production of short-lived, functional T cells","volume":"29","author":"Snyder","year":"2008","journal-title":"Immunity"},{"issue":"8376","key":"10.1016\/j.vaccine.2009.04.036_bib13","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0140-6736(84)90930-9","article-title":"Towne-vaccine-induced prevention of cytomegalovirus disease after renal transplants","volume":"1","author":"Plotkin","year":"1984","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.vaccine.2009.04.036_bib14","first-page":"289","article-title":"Cytomegalovirus vaccine in renal transplant candidates: progress report of a randomized, placebo-controlled, double-blind trial","volume":"20","author":"Balfour","year":"1984","journal-title":"Birth Defects Orig Artic Ser"},{"issue":"12","key":"10.1016\/j.vaccine.2009.04.036_bib15","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1001\/archsurg.1988.01400360072012","article-title":"Prophylaxis of serious cytomegalovirus infection in renal transplant candidates using live human cytomegalovirus vaccine. Interim results of a randomized controlled trial","volume":"123","author":"Brayman","year":"1988","journal-title":"Arch Surg"},{"issue":"7","key":"10.1016\/j.vaccine.2009.04.036_bib16","doi-asserted-by":"crossref","first-page":"525","DOI":"10.7326\/0003-4819-114-7-525","article-title":"Effect of Towne live virus vaccine on cytomegalovirus disease after renal transplant. A controlled trial","volume":"114","author":"Plotkin","year":"1991","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1016\/j.vaccine.2009.04.036_bib17","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1097\/00007890-199412150-00006","article-title":"Multicenter trial of Towne strain attenuated virus vaccine in seronegative renal transplant recipients","volume":"58","author":"Plotkin","year":"1994","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.vaccine.2009.04.036_bib18","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/infdis\/171.1.26","article-title":"Immunity induced by primary human cytomegalovirus infection protects against secondary infection among women of childbearing age","volume":"171","author":"Adler","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2009.04.036_bib19","first-page":"333","article-title":"Cytomegalovirus immune evasion","volume":"325","author":"Powers","year":"2008","journal-title":"Curr Top Microbiol Immunol"},{"issue":"24","key":"10.1016\/j.vaccine.2009.04.036_bib20","doi-asserted-by":"crossref","first-page":"13825","DOI":"10.1128\/JVI.01911-07","article-title":"Targeted deletion of regions rich in immune-evasive genes from the cytomegalovirus genome as a novel vaccine strategy","volume":"81","author":"Cicin-Sain","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2009.04.036_bib21","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/jmv.1890230106","article-title":"Congenital cytomegalovirus: immunologic alterations","volume":"23","author":"Cauda","year":"1987","journal-title":"J Med Virol"},{"issue":"11","key":"10.1016\/j.vaccine.2009.04.036_bib22","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1038\/ni1102-1019","article-title":"Viral interference with antigen presentation","volume":"3","author":"Yewdell","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2009.04.036_bib23","first-page":"117","article-title":"Viral evasion of natural killer cells during human cytomegalovirus infection","volume":"269","author":"Braud","year":"2002","journal-title":"Curr Top Microbiol Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2009.04.036_bib24","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1399-0039.2004.00210.x","article-title":"Natural killer cell receptors for major histocompatibility complex class I and related molecules in cytomegalovirus infection","volume":"63","author":"Lopez-Botet","year":"2004","journal-title":"Tissue Antigens"},{"issue":"3","key":"10.1016\/j.vaccine.2009.04.036_bib25","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1084\/jem.190.3.435","article-title":"m144, a murine cytomegalovirus (MCMV)-encoded major histocompatibility complex class I homologue, confers tumor resistance to natural killer cell-mediated rejection","volume":"190","author":"Cretney","year":"1999","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.vaccine.2009.04.036_bib26","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1006\/cimm.1998.1424","article-title":"Inhibition of NK cells by murine CMV-encoded class I MHC homologue m144","volume":"191","author":"Kubota","year":"1999","journal-title":"Cell Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2009.04.036_bib27","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1084\/jem.187.10.1681","article-title":"Modulation of natural killer cell cytotoxicity in human cytomegalovirus infection: the role of endogenous class I major histocompatibility complex and a viral class I homolog","volume":"187","author":"Leong","year":"1998","journal-title":"J Exp Med"},{"issue":"6624","key":"10.1016\/j.vaccine.2009.04.036_bib28","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/386514a0","article-title":"The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells","volume":"386","author":"Reyburn","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2009.04.036_bib29","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2172-4-4","article-title":"Expression of the UL16 glycoprotein of human cytomegalovirus protects the virus-infected cell from attack by natural killer cells","volume":"4","author":"Vales-Gomez","year":"2003","journal-title":"BMC Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2009.04.036_bib30","doi-asserted-by":"crossref","first-page":"7457","DOI":"10.4049\/jimmunol.175.11.7457","article-title":"Human cytomegalovirus encodes an MHC class I-like molecule (UL142) that functions to inhibit NK cell lysis","volume":"175","author":"Wills","year":"2005","journal-title":"J Immunol"},{"issue":"14","key":"10.1016\/j.vaccine.2009.04.036_bib31","doi-asserted-by":"crossref","first-page":"7536","DOI":"10.1128\/JVI.78.14.7536-7544.2004","article-title":"Gain of virulence caused by loss of a gene in murine cytomegalovirus","volume":"78","author":"Bubic","year":"2004","journal-title":"J Virol"},{"issue":"6624","key":"10.1016\/j.vaccine.2009.04.036_bib32","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/386510a0","article-title":"Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo","volume":"386","author":"Farrell","year":"1997","journal-title":"Nature"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2009.04.036_bib33","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/S1386-6532(02)00100-2","article-title":"Animal models of congenital cytomegalovirus infection: an overview of progress in the characterization of guinea pig cytomegalovirus (GPCMV)","volume":"25","author":"Schleiss","year":"2002","journal-title":"J Clin Virol"},{"key":"10.1016\/j.vaccine.2009.04.036_bib34","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1743-422X-3-42","article-title":"Pathogenesis and vertical transmission of a transplacental rat cytomegalovirus","volume":"3","author":"Loh","year":"2006","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2009.04.036_bib35","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1743-422X-4-26","article-title":"Transplacental murine cytomegalovirus infection in the brain of SCID mice","volume":"4","author":"Woolf","year":"2007","journal-title":"Virol J"},{"issue":"5","key":"10.1016\/j.vaccine.2009.04.036_bib36","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/infdis\/138.5.650","article-title":"Experimental congenital infection with cytomegalovirus: a guinea pig model","volume":"138","author":"Kumar","year":"1978","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2009.04.036_bib37","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1128\/JVI.55.2.402-409.1985","article-title":"The placenta as a site of cytomegalovirus infection in guinea pigs","volume":"55","author":"Griffith","year":"1985","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2009.04.036_bib38","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/infdis\/120.4.445","article-title":"Mouse cytomegalovirus: placental infection","volume":"120","author":"Johnson","year":"1969","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2009.04.036_bib39","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1086\/320714","article-title":"Modification of maternal and congenital cytomegalovirus infection by anti-glycoprotein b antibody transfer in guinea pigs","volume":"183","author":"Chatterjee","year":"2001","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2009.04.036_bib40","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1086\/499603","article-title":"Effect of maternal treatment with cyclic HPMPC in the guinea pig model of congenital cytomegalovirus infection","volume":"193","author":"Bravo","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2009.04.036_bib41","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1743-422X-3-9","article-title":"Cyclic cidofovir (cHPMPC) prevents congenital cytomegalovirus infection in a guinea pig model","volume":"3","author":"Schleiss","year":"2006","journal-title":"Virol J"},{"issue":"37\u201339","key":"10.1016\/j.vaccine.2009.04.036_bib42","doi-asserted-by":"crossref","first-page":"6175","DOI":"10.1016\/j.vaccine.2006.06.077","article-title":"Protection against congenital cytomegalovirus (CMV) disease, conferred by a replication-disabled, bacterial artificial chromosome (BAC)-based DNA vaccine","volume":"24","author":"Schleiss","year":"2006","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2009.04.036_bib43","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/ilar.47.1.65","article-title":"Nonprimate models of congenital cytomegalovirus (CMV) infection: gaining insight into pathogenesis and prevention of disease in newborns","volume":"47","author":"Schleiss","year":"2006","journal-title":"ILAR J"},{"issue":"6","key":"10.1016\/j.vaccine.2009.04.036_bib44","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1086\/511982","article-title":"Preconceptual administration of an alphavirus replicon UL83 (pp65 homolog) vaccine induces humoral and cellular immunity and improves pregnancy outcome in the guinea pig model of congenital cytomegalovirus infection","volume":"195","author":"Schleiss","year":"2007","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2009.04.036_bib45","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jcv.2007.10.008","article-title":"Comparison of vaccine strategies against congenital CMV infection in the guinea pig model","volume":"41","author":"Schleiss","year":"2008","journal-title":"J Clin Virol"},{"key":"10.1016\/j.vaccine.2009.04.036_bib46","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/1743-422X-5-139","article-title":"Analysis of the nucleotide sequence of a BAC-derived clone of the guinea pig cytomegalovirus (GPCMV) genome","volume":"5","author":"Schleiss","year":"2008","journal-title":"Virol J"},{"issue":"2","key":"10.1016\/j.vaccine.2009.04.036_bib47","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jviromet.2008.01.031","article-title":"Cloning the complete guinea pig cytomegalovirus genome as an infectious bacterial artificial chromosome with excisable origin of replication","volume":"149","author":"Cui","year":"2008","journal-title":"J Virol Methods"},{"issue":"5","key":"10.1016\/j.vaccine.2009.04.036_bib48","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1128\/jvi.76.5.2316-2328.2002","article-title":"Construction of a self-excisable bacterial artificial chromosome containing the human cytomegalovirus genome and mutagenesis of the diploid TRL\/IRL13 gene","volume":"76","author":"Yu","year":"2002","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2009.04.036_bib49","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1093\/nar\/gni035","article-title":"Simple and highly efficient BAC recombineering using galK selection","volume":"33","author":"Warming","year":"2005","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"10.1016\/j.vaccine.2009.04.036_bib50","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1128\/JVI.68.2.1040-1051.1994","article-title":"Human cytomegalovirus DNA replicates after early circularization by concatemer formation, and inversion occurs within the concatemer","volume":"68","author":"McVoy","year":"1994","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2009.04.036_bib51","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1099\/vir.0.18675-0","article-title":"Down-regulation of surface major histocompatibility complex class I by guinea pig cytomegalovirus","volume":"84","author":"Lacayo","year":"2003","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2009.04.036_bib52","series-title":"Cytomegaloviruses: molecular biology and immunology","first-page":"525","article-title":"The guinea-pig model of congenital CMV infection","author":"Schleiss","year":"2006"},{"issue":"8","key":"10.1016\/j.vaccine.2009.04.036_bib53","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1086\/382751","article-title":"Protection against congenital cytomegalovirus infection and disease in guinea pigs, conferred by a purified recombinant glycoprotein B vaccine","volume":"189","author":"Schleiss","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2009.04.036_bib54","doi-asserted-by":"crossref","first-page":"5760","DOI":"10.1016\/j.vaccine.2008.07.092","article-title":"Cytomegalovirus vaccines fail to induce epithelial entry neutralizing antibodies comparable to natural infection","volume":"26","author":"Cui","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.04.036_bib55","doi-asserted-by":"crossref","first-page":"4271","DOI":"10.1128\/IAI.71.8.4271-4277.2003","article-title":"Coordinate cytokine gene expression in vivo following induction of tuberculous pleurisy in guinea pigs","volume":"71","author":"Allen","year":"2003","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2009.04.036_bib56","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.4049\/jimmunol.171.5.2366","article-title":"Dendritic cells mediate NK cell help for Th1 and CTL responses: two-signal requirement for the induction of NK cell helper function","volume":"171","author":"Mailliard","year":"2003","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2009.04.036_bib57","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1086\/379839","article-title":"Preconception vaccination with a glycoprotein B (gB) DNA vaccine protects against cytomegalovirus (CMV) transmission in the guinea pig model of congenital CMV infection","volume":"188","author":"Schleiss","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2009.04.036_bib58","doi-asserted-by":"crossref","first-page":"6723","DOI":"10.4049\/jimmunol.175.10.6723","article-title":"MyD88-dependent and -independent murine cytomegalovirus sensing for IFN-alpha release and initiation of immune responses in vivo","volume":"175","author":"Delale","year":"2005","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2009.04.036_bib59","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s007050200028","article-title":"A rat cytomegalovirus strain with a disruption of the r144 MHC class I-like gene is attenuated in the acute phase of infection in neonatal rats","volume":"147","author":"Kloover","year":"2002","journal-title":"Arch Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2009.04.036_bib60","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.cell.2006.02.019","article-title":"Translating innate immunity into immunological memory: implications for vaccine development","volume":"124","author":"Pulendran","year":"2006","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.vaccine.2009.04.036_bib61","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.molimm.2004.07.025","article-title":"NK cell regulation of T cell-mediated responses","volume":"42","author":"Zingoni","year":"2005","journal-title":"Mol Immunol"},{"key":"10.1016\/j.vaccine.2009.04.036_bib62","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1128\/JVI.52.1.119-128.1984","article-title":"Pathogenesis of murine cytomegalovirus infection in natural killer cell-depleted mice","volume":"52","author":"Bukowski","year":"1984","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2009.04.036_bib63","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0952-7915(00)00241-7","article-title":"NK cells and NKT cells in innate defense against viral infections","volume":"13","author":"Biron","year":"2001","journal-title":"Curr Opin Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.04.036_bib64","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1053\/j.semperi.2007.01.002","article-title":"Recent advances in the prevention and treatment of congenital cytomegalovirus infections","volume":"31","author":"Adler","year":"2007","journal-title":"Semin Perinatol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09005817?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09005817?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T22:05:27Z","timestamp":1589753127000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09005817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":64,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S0264410X09005817"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.04.036","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}